124 related articles for article (PubMed ID: 15037720)
1. Focal dystonia caused by Mohr-Tranebjaerg syndrome with complete deletion of the DDP1 gene.
Pizzuti A; Fabbrini G; Salehi L; Vacca L; Inghilleri M; Dallapiccola B; Berardelli A
Neurology; 2004 Mar; 62(6):1021-2. PubMed ID: 15037720
[No Abstract] [Full Text] [Related]
2. A contiguous deletion syndrome of X-linked agammaglobulinemia and sensorineural deafness.
Richter D; Conley ME; Rohrer J; Myers LA; Zahradka K; Kelecić J; Sertić J; Stavljenić-Rukavina A
Pediatr Allergy Immunol; 2001 Apr; 12(2):107-11. PubMed ID: 11338284
[TBL] [Abstract][Full Text] [Related]
3. Dystonia in the Mohr-Tranebjaerg syndrome responds to GABAergic substances.
Kreisel SH; Binder J; Wöhrle JC; Krauss JK; Hofmann S; Bauer MF; Hennerici MG; Bäzner H
Mov Disord; 2004 Oct; 19(10):1241-3. PubMed ID: 15390009
[TBL] [Abstract][Full Text] [Related]
4. A Spanish sporadic case of deafness-dystonia (Mohr-Tranebjaerg) syndrome with a novel mutation in the gene encoding TIMM8a, a component of the mitochondrial protein translocase complexes.
Aguirre LA; Pérez-Bas M; Villamar M; López-Ariztegui MA; Moreno-Pelayo MA; Moreno F; del Castillo I
Neuromuscul Disord; 2008 Dec; 18(12):979-81. PubMed ID: 18952432
[TBL] [Abstract][Full Text] [Related]
5. Contiguous X-chromosome deletion syndrome encompassing the BTK, TIMM8A, TAF7L, and DRP2 genes.
Sedivá A; Smith CI; Asplund AC; Hadac J; Janda A; Zeman J; Hansíková H; Dvoráková L; Mrázová L; Velbri S; Koehler C; Roesch K; Sullivan KE; Futatani T; Ochs HD
J Clin Immunol; 2007 Nov; 27(6):640-6. PubMed ID: 17851739
[TBL] [Abstract][Full Text] [Related]
6. Genetic analysis of contiguous X-chromosome deletion syndrome encompassing the BTK and TIMM8A genes.
Arai T; Zhao M; Kanegane H; van Zelm MC; Futatani T; Yamada M; Ariga T; Ochs HD; Miyawaki T; Oh-ishi T
J Hum Genet; 2011 Aug; 56(8):577-82. PubMed ID: 21753765
[TBL] [Abstract][Full Text] [Related]
7. Xq22.1 contiguous gene deletion syndrome of X-linked agammaglobulinemia and Mohr-Tranebjærg syndrome.
Shaker M; Lorigiano TH; Vadlamudi A
Ann Allergy Asthma Immunol; 2016 Jun; 116(6):578-9. PubMed ID: 27048950
[No Abstract] [Full Text] [Related]
8. Phenotype prediction of Mohr-Tranebjaerg syndrome (MTS) by genetic analysis and initial auditory neuropathy.
Wang H; Wang L; Yang J; Yin L; Lan L; Li J; Zhang Q; Wang D; Guan J; Wang Q
BMC Med Genet; 2019 Jan; 20(1):11. PubMed ID: 30634948
[TBL] [Abstract][Full Text] [Related]
9. Clinical and molecular findings in a patient with a novel mutation in the deafness-dystonia peptide (DDP1) gene.
Binder J; Hofmann S; Kreisel S; Wöhrle JC; Bäzner H; Krauss JK; Hennerici MG; Bauer MF
Brain; 2003 Aug; 126(Pt 8):1814-20. PubMed ID: 12805099
[TBL] [Abstract][Full Text] [Related]
10. Blepharospasm and limb dystonia caused by Mohr-Tranebjaerg syndrome with a novel splice-site mutation in the deafness/dystonia peptide gene.
Kim HT; Edwards MJ; Tyson J; Quinn NP; Bitner-Glindzicz M; Bhatia KP
Mov Disord; 2007 Jul; 22(9):1328-31. PubMed ID: 17534980
[TBL] [Abstract][Full Text] [Related]
11. A novel intronic mutation in the DDP1 gene in a family with X-linked dystonia-deafness syndrome.
Ezquerra M; Campdelacreu J; Muñoz E; Tolosa E; Martí MJ
Arch Neurol; 2005 Feb; 62(2):306-8. PubMed ID: 15710860
[TBL] [Abstract][Full Text] [Related]
12. A novel deafness/dystonia peptide gene mutation that causes dystonia in female carriers of Mohr-Tranebjaerg syndrome.
Swerdlow RH; Wooten GF
Ann Neurol; 2001 Oct; 50(4):537-40. PubMed ID: 11601506
[TBL] [Abstract][Full Text] [Related]
13. Molecular genetics of a patient with Mohr-Tranebjaerg Syndrome due to a new mutation in the DDP1 gene.
Blesa JR; Solano A; Briones P; Prieto-Ruiz JA; Hernández-Yago J; Coria F
Neuromolecular Med; 2007; 9(4):285-91. PubMed ID: 17999202
[TBL] [Abstract][Full Text] [Related]
14. [Mohr-Tranebjaerg syndrome].
Yamamoto K; Ikeda S
Nihon Rinsho; 2002 Apr; 60 Suppl 4():385-8. PubMed ID: 12013893
[No Abstract] [Full Text] [Related]
15. Transient myelodysplastic syndrome in X-linked agammaglobulinemia with a novel Btk mutation.
Narula G; Currimbhoy Z
Pediatr Blood Cancer; 2008 Dec; 51(6):826-8. PubMed ID: 18726917
[TBL] [Abstract][Full Text] [Related]
16. Iris atrophy in a patient with X-linked agammaglobulinemia.
Reisli I; Artac H; van der Burg M; Ozturk BT
Can J Ophthalmol; 2007 Dec; 42(6):882-3. PubMed ID: 18059520
[No Abstract] [Full Text] [Related]
17. X-linked agammaglobulinemia caused by new mutation in BTK gene: a case report.
Havlicekova Z; Jesenak M; Freiberger T; Banovcin P
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014 Sep; 158(3):470-3. PubMed ID: 23549506
[TBL] [Abstract][Full Text] [Related]
18. The lack of BTK does not impair monocytes and polymorphonuclear cells functions in X-linked agammaglobulinemia under treatment with intravenous immunoglobulin replacement.
Cavaliere FM; Prezzo A; Bilotta C; Iacobini M; Quinti I
PLoS One; 2017; 12(4):e0175961. PubMed ID: 28422989
[TBL] [Abstract][Full Text] [Related]
19. Human deafness dystonia syndrome is caused by a defect in assembly of the DDP1/TIMM8a-TIMM13 complex.
Roesch K; Curran SP; Tranebjaerg L; Koehler CM
Hum Mol Genet; 2002 Mar; 11(5):477-86. PubMed ID: 11875042
[TBL] [Abstract][Full Text] [Related]
20. Dermatofibrosarcoma protuberans in a patient with X-linked agammaglobulinaemia.
Yong PF; Grosse-Kreul D; Maher J; Salisbury JR; Ibrahim MA
J Clin Pathol; 2007 Oct; 60(10):1162-4. PubMed ID: 17906069
[No Abstract] [Full Text] [Related]
[Next] [New Search]
